VanEck Biotech ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBH and other ETFs, options, and stocks.

About BBH

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally. 

Index-Tracked
MSCI ACWI NR USD
Index-TrackedMSCI ACWI NR USD
Category
Health
CategoryHealth
Number of holdings
26
Number of holdings26
Inception Date
Dec 20, 2011
Inception DateDec 20, 2011

What's in this fund

Sectors

As of November 13, 2025
Healthcare100.00%

BBH Key Statistics

AUM
369.43M
AUM369.43M
Price-Earnings ratio
38.29
Price-Earnings ratio38.29
30-Day yield
0.43
30-Day yield0.43
Average volume
9.45K
Average volume9.45K
High today
$189.47
High today$189.47
Low today
$187.07
Low today$187.07
Open price
$187.51
Open price$187.51
Volume
4.04K
Volume4.04K
52 Week high
$191.19
52 Week high$191.19
52 Week low
$135.34
52 Week low$135.34
Expense ratio
0.35
Expense ratio0.35

Stock Snapshot

The current VanEck Biotech ETF(BBH) stock price is $188.05, with a market capitalization of 369.8M. The stock trades at a price-to-earnings (P/E) ratio of 38.29 and offers a dividend yield of 72.3%.

During the trading session on 2025-11-14, VanEck Biotech ETF(BBH) shares reached a daily high of $189.47 and a low of $187.07. At a current price of $188.05, the stock is +0.5% higher than the low and still -0.7% under the high.

Trading volume for VanEck Biotech ETF(BBH) stock has reached 4.04K, versus its average volume of 9.45K.

Over the past 52 weeks, VanEck Biotech ETF(BBH) stock has traded between a high of $191.19 and a low of $135.34.

Over the past 52 weeks, VanEck Biotech ETF(BBH) stock has traded between a high of $191.19 and a low of $135.34.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.